Stemcell United Limited advised that following completion of the capital raising and confirmation that the Company has satisfied ASX's conditions for reinstatement, the following Board and management changes are planned to occur: Mr. Philip Gu will step down as CEO of the Company but shall remain as a director of the Company focused on guiding the Science and R&D for the Company's traditional medicine business together with its plant stem cell technology.